CHINA HEALTH GRP HD-10 - Asset Resilience Ratio

Latest as of June 2025: 1.54%

CHINA HEALTH GRP HD-10 (VNL1) has an Asset Resilience Ratio of 1.54% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is CHINA HEALTH GRP HD-10's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€1.70 Million

≈ $1.98 Million USD Cash + Short-term Investments

Total Assets

€110.02 Million

≈ $128.62 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how CHINA HEALTH GRP HD-10's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see VNL1 asset base.

Liquid Assets Composition Over Time

This chart breaks down CHINA HEALTH GRP HD-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CHINA HEALTH GRP HD-10 debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.70 Million	1.54%
Total Liquid Assets	€1.70 Million	1.54%

Asset Resilience Insights

Limited Liquidity: CHINA HEALTH GRP HD-10 maintains only 1.54% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CHINA HEALTH GRP HD-10 Industry Peers by Asset Resilience Ratio

Compare CHINA HEALTH GRP HD-10's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10 F:LO3A	Diagnostics & Research	3.04%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Gencurix Inc KQ:229000	Diagnostics & Research	4.01%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for CHINA HEALTH GRP HD-10 (2021–2024)

The table below shows the annual Asset Resilience Ratio data for CHINA HEALTH GRP HD-10.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.68%	€1.70 Million ≈ $1.98 Million	€100.96 Million ≈ $118.03 Million	-0.97pp
2023-12-31	2.65%	€3.16 Million ≈ $3.70 Million	€119.35 Million ≈ $139.53 Million	-1.83pp
2022-12-31	4.48%	€8.01 Million ≈ $9.36 Million	€178.62 Million ≈ $208.83 Million	+1.57pp
2021-12-31	2.91%	€5.66 Million ≈ $6.62 Million	€194.32 Million ≈ $227.19 Million	--

pp = percentage points

About CHINA HEALTH GRP HD-10

F:VNL1 Germany Diagnostics & Research

Market Cap

$581.84K

€497.68K EUR

Market Cap Rank

#30993 Global

#2726 in Germany

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.07